SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000920465-20-000130
Filing Date
2020-08-07
Accepted
2020-08-07 20:19:41
Documents
2
Period of Report
2020-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_159684596516916.html 3  
1 FORM 3 wf-form3_159684596516916.xml 3 3141
2 POWER OF ATTORNEY, LARRY EDWARDS ex-24.htm EX-24 3575
  Complete submission text file 0000920465-20-000130.txt   8120
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL STREET, SUITE 110 WATERTOWN MA 02472
Business Address
Edwards Larry G. (Reporting) CIK: 0001733062 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36282 | Film No.: 201086460